{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T21:40:17Z","timestamp":1736026817092,"version":"3.32.0"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T00:00:00Z","timestamp":1128643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:p><jats:bold>Objective\u2002<\/jats:bold>Logistics and cost of nucleic acid amplification testing (NAT) screening preclude its current use in many developing countries. Development of hepatitis C virus (HCV) core antigen assays offer an alternative to NAT. We evaluated two specimen populations to assess the sensitivity, relative to NAT, of the HCV core antigen (HCVcAg) ELISA (enzyme\u2010linked immunosorbent assay) test system and the trak\u2010C assay: (1) plasma donor HCV NAT\u2010conversion panels and (2) cross\u2010sectional whole blood donor NAT yield specimens.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold>Differential sensitivities among NAT (NGI; Chiron\/Gen\u2010Probe) and both HCVcAg assays (Ortho\u2010Clinical Diagnostics, Rochester, NY) were evaluated using: (1) 102 serial ramp\u2010up phase specimens from 37 plasma donor NAT\u2010conversion panels (Alpha Therapeutic\/BioClinical Partners); and (2) 42 cross\u2010sectional whole blood donor NAT yield specimens (confirmed RNA positive, antibody negative) plus 54 NAT false\u2010positive specimens (American Red Cross).<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold>Viral load among the plasma donor NAT\u2010conversion panels at the cutoffs for HCVcAg and trak\u2010C assays were 32\u00a0000 copies\/ml (95% confidence interval [CI] 8000\u2013120\u00a0000) and 8000 copies\/ml (95% CI: 2200\u201328\u00a0000), respectively. The mean (95% CI) difference in window period reduction compared to routine mini\u2010pool NAT screening (estimated sensitivity 100 copies\/ml) was delayed 5\u00b72\u00a0days (2\u00b72\u20137\u00b76\u00a0days) for HCVcAg assay and 3\u00b78\u00a0days (2\u00b71\u20135\u00b75\u00a0days) for the trak\u2010C assay. Among the 42 NAT yield specimens, the HCVcAg assay detected 31 (74%) as core antigen\u2010positive while the trak\u2010C assay detected 37 (88%) as core antigen\u2010positive. Viral loads for the five specimens not detected by the trak\u2010C HCVcAg assay ranged from 100 to 7770 copies\/ml. All 54 NAT false\u2010positive specimens were non\u2010reactive on both HCV core antigen assays.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold>These data indicate that the trak\u2010C assay has sensitivity approaching routine mini\u2010pool NAT screening for the detection of seronegative HCV infection. In the absence of routine NAT screening for early HCV infection, the use of an HCV core antigen assay should be considered.<\/jats:p>","DOI":"10.1111\/j.1423-0410.2005.00687.x","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T14:46:45Z","timestamp":1128696405000},"page":"201-207","source":"Crossref","is-referenced-by-count":16,"title":["Performance of ORTHO\u00ae HCV core antigen and trak\u2010C\u2122 assays for detection of viraemia in pre\u2010seroconversion plasma and whole blood donors"],"prefix":"10.1111","volume":"89","author":[{"given":"L. H.","family":"Tobler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Stramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Baggett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hirschkorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,7]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_6_2_2","DOI":"10.1056\/NEJM200107053450107"},{"doi-asserted-by":"publisher","key":"e_1_2_6_3_2","DOI":"10.1046\/j.1537-2995.1995.351196110893.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_4_2","DOI":"10.1046\/j.1537-2995.2002.00166.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_5_2","DOI":"10.1111\/j.1537-2995.2005.04390.x"},{"issue":"200","key":"e_1_2_6_6_2","article-title":"Insight into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients","volume":"8","author":"Busch MP","year":"2001","journal-title":"Transfus Clin Biol"},{"key":"e_1_2_6_7_2","first-page":"93","article-title":"Polymerase chain reaction in detecting hepatitis C virus among blood donors","volume":"102","author":"Mosley JW","year":"2000","journal-title":"Dev Biol"},{"doi-asserted-by":"publisher","key":"e_1_2_6_8_2","DOI":"10.1084\/jem.194.10.1395"},{"doi-asserted-by":"publisher","key":"e_1_2_6_9_2","DOI":"10.1002\/jmv.1890360314"},{"key":"e_1_2_6_10_2","article-title":"Large scale PCR screening of pooled plasma samples for HIV\u20101 and HCV","volume":"102","author":"Smith R","year":"2000","journal-title":"Dev Biol Stand"},{"doi-asserted-by":"publisher","key":"e_1_2_6_11_2","DOI":"10.1089\/jir.1998.18.75"},{"doi-asserted-by":"publisher","key":"e_1_2_6_12_2","DOI":"10.1056\/NEJMoa040085"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1053\/jhep.2002.36815","article-title":"Use and interpretation of virological tests for hepatitis C","volume":"36","author":"Pawlotsky JM","year":"2002","journal-title":"Hepatology"},{"doi-asserted-by":"publisher","key":"e_1_2_6_14_2","DOI":"10.1016\/S0166-0934(02)00012-5"},{"doi-asserted-by":"publisher","key":"e_1_2_6_15_2","DOI":"10.1002\/9780470316856"},{"doi-asserted-by":"publisher","key":"e_1_2_6_16_2","DOI":"10.1046\/j.1537-2995.2002.00174.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_17_2","DOI":"10.1046\/j.1537-2995.2002.00200.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_18_2","DOI":"10.1046\/j.1537-2995.2001.41091172.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_19_2","DOI":"10.1046\/j.1537-2995.2003.00430.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_20_2","DOI":"10.1128\/JCM.37.6.1802-1808.1999"},{"doi-asserted-by":"publisher","key":"e_1_2_6_21_2","DOI":"10.1046\/j.1423-0410.2000.7820080.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_22_2","DOI":"10.1046\/j.1537-2995.2000.40101198.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_23_2","DOI":"10.1046\/j.1423-0410.2001.00008.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_24_2","DOI":"10.1128\/JCM.39.9.3110-3114.2001"},{"doi-asserted-by":"publisher","key":"e_1_2_6_25_2","DOI":"10.1046\/j.1537-2995.2001.41020304.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_26_2","DOI":"10.1111\/j.1537-2995.2004.03340.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_27_2","DOI":"10.1046\/j.1525-1438.2002.00104.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_28_2","DOI":"10.1053\/jhep.2000.9112"},{"doi-asserted-by":"publisher","key":"e_1_2_6_29_2","DOI":"10.1053\/jhep.2002.34130"},{"doi-asserted-by":"publisher","key":"e_1_2_6_30_2","DOI":"10.1046\/j.1423-0410.1999.7630149.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_31_2","DOI":"10.1016\/S0140-6736(02)08663-4"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1423-0410.2005.00687.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1423-0410.2005.00687.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T21:03:27Z","timestamp":1736024607000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1423-0410.2005.00687.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1111\/j.1423-0410.2005.00687.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1423-0410.2005.00687.x","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"type":"print","value":"0042-9007"},{"type":"electronic","value":"1423-0410"}],"subject":[],"published":{"date-parts":[[2005,10,7]]}}}